Chemistry:Asimilobine

From HandWiki

Asimilobine, also known as (R)-1-methoxy-2-hydroxynoraporphine, is a noraporphine alkaloid with various known pharmacological actions.[1][2] It has been found to act as a selective biased partial agonist of the serotonin 5-HT2C receptor, with an EC50 of 308 nM and Emax of 86% for activation of Gq signaling and no β-arrestin2 recruitment.[3] Conversely, asimilobine was inactive as an agonist of the serotonin 5-HT2A and 5-HT2B receptors, but did show weak antagonism of these receptors at very high concentrations (IC50 = >10,000 nM).[3] Derivatives and analogues of asimilobine with more potent serotonin 5-HT2C receptor agonism, such as 11-chloroasimilobine, have been studied and described.[4][5] In addition, derivatives with dual highly potent serotonin 5-HT2A and 5-HT2C receptor agonism, such as 11-methoxyasimilobine, have been described.[4][5]

(RS)-Asimilobine.

Although asimilobine is inactive as an agonist of the serotonin 5-HT2A and 5-HT2C receptors, the racemic form of the compound has been found to act as an agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors, with EC50 (Emax) values of 318 nM (55%), 794 nM (25%), and 51 nM (94%), respectively.[6][7] The 1-propoxy homologue shows more potent serotonin 5-HT2A and 5-HT2B receptor agonism and less potent serotonin 5-HT2C receptor agonism (EC50 (Emax) = 43 nM (91%), 53 nM (81%), and 197 nM (98%), respectively).[6][8]

See also

  • Noraporphine
  • Aporphine alkaloid
  • Nornuciferine
  • 11-Chloroasimilobine
  • 11-Methoxyasimilobine
  • MQ02-439

References

  1. Shoji, N; Umeyama, A; Saito, N; Iuchi, A; Takemoto, T; Kajiwara, A; Ohizumi, Y (1987). "Asimilobine and lirinidine, serotonergic receptor antagonists, from Nelumbo nucifera". Journal of Natural Products 50 (4): 773–4. doi:10.1021/np50052a044. PMID 3430176. Bibcode1987JNAtP..50..773S. 
  2. Jin, CM; Lee, JJ; Kim, YK; Ryu, SY; Lim, SC; Hwang, BY; Lee, CK; Lee, MK (2008). "Effects of asimilobine on dopamine biosynthesis and l-DOPA-induced cytotoxicity in PC12 cells". Journal of Asian Natural Products Research 10 (7–8): 747–55. doi:10.1080/10286020802030892. PMID 18696327. 
  3. 3.0 3.1 "A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts". ACS Cent Sci 6 (2): 213–225. February 2020. doi:10.1021/acscentsci.9b01125. PMID 32123739. 
  4. 4.0 4.1 "Discovery of New N-H Aporphine Derivatives As Brain-Penetrant Gq-Biased 5-HT2C Receptor Agonists and Dual 5-HT2C/5-HT2A Receptor Agonists". Journal of Medicinal Chemistry 68 (21): 23300–23323. November 2025. doi:10.1021/acs.jmedchem.5c02115. PMID 41108743. 
  5. 5.0 5.1 "Aporphine derivative and preparation method and application thereof". 14 June 2022. https://patents.google.com/patent/CN115108986A/en. 
  6. 6.0 6.1 "Structural optimizations and bioevaluation of N-H aporphine analogues as Gq-biased and selective serotonin 5-HT2C receptor agonists". Bioorg Chem 123. June 2022. doi:10.1016/j.bioorg.2022.105795. PMID 35430417. 
  7. "1-Methoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,gquinolin-2-ol"]. https://pubchem.ncbi.nlm.nih.gov/compound/12308663. 
  8. Bergwerf, Herman. [de,gquinolin-2-ol "MolView"]. https://molview.org/?q=1-Propoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-2-ol.